linkedin post 2018-04-10 03:37:29

Uncategorized
OBSCURED GENE SYSTEMS. “While these methods incorporate parameterizations to account for the high dimensional nature of genomics data, such as pooled variance estimates or multiple testing correction, they completely ignore the interactions of genes as parts of large-scale biological pathways and system.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-10 03:35:50

Uncategorized
OCCLUDED MOLECULAR SYSTEMS. “There are still methodological and conceptual limitations that must be overcome to bridge the gap between simple gene expression analysis and the inference of molecular systems. For example, most of the popular differential gene expression methods that are used for variable selection provide single gene-based assessments of differential expression.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-09 03:10:50

Uncategorized
THE UNDERDETERMINATION PROBLEM. “This inference is complicated by the high variable to observation ratio of genomics, which causes the intrinsic and heavily underdetermined nature of the genomics/systems biology marriage. Experimental designs involving time courses and or perturbation can provide significantly more, but rarely enough, information on the underlying system structure. Computational biologists address this high underdetermination problem using strategies such as variable selection.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-09 03:08:10

Uncategorized
AN INFERRED STRUCTURE. “While the measurement of expression genome-wide is only the first step in deriving system-level knowledge, it presents analytical challenges to this day. The main reason is that genomic experimental techniques measure individual parts of the system in parallel but cannot directly measure the system structure, which needs to be inferred.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-11 04:15:24

Uncategorized
METABOLIC HUBS. “Flux balance analysis can be integratively analyzed with genome-wide data by incorporating gene expression measurements into metabolic modeling. This combination enables the characterization of the regulatory modalities governing metabolism and for the identification of metabolic hubs.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-09 03:06:50

Uncategorized
ALL ABOUT EXPRESSING THE BLUEPRINT. “Whereas the elements that make up the genetic definition of living organisms are encoded into the genome, it is the ensemble of expressed genes that are the actual manifestation of the biological system.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-11 04:14:32

Uncategorized
MOLECULAR NETWORKS. “The concept of molecular networks extends beyond gene regulatory networks. In fact, much of the early research in systems biology focused on flux balance analysis (FBA), which is a genome-wide analysis of metabolic regulation.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-09 03:03:56

Uncategorized
DATA RICHNESS. “The transformation of biology by genomics from a relatively data-poor into a data-intensive field has motivated the development of novel computational, machine-learning and other quantitative methods for genomic analysis that attracted a large number of engineers, physicists, and mathematicians into biology.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More

linkedin post 2018-04-13 16:35:16

Uncategorized
UNRESOLVED ISSUES. “While it is rare that cataloguing mutations in cancer alone will reveal both mechanisms of disease progression and potential drugable targets, we are left with the greater challenge of understanding how some cancers can relapse after treatment.” https://bmcsystbiol.biomedcentral.com/articles/10.1186/1752-0509-8-S2-S1 View in LinkedIn
Read More